The ultimate goal from these products is to look younger by reducing the appearance of lines and wrinkles. Neither Botox, Dysport, or XEOMIN® were specifically developed for the use on facial wrinkles. They were developed as a therapeutic drug for nerve and muscle disturbances, but are now being used by doctors all over the world, as a temporary solution for facial lines and wrinkles. Each of the drugs has similarities, and some subtle differences.
XEOMIN® (incobotulinumtoxinA) approved to treat abnormal head positions and neck pain, associated with cervical dystonia (CD). It was also approved to treat blepharospasm, or abnormal spasms of the eyelids. It has evolved into facial aesthetics, treating facial lines and wrinkles, by blocking nerve to muscle signals temporarily. Xeomin blocks the release of acetylcholine, the chemical messenger to the muscle, causing the muscle to decrease activity, or temporarily paralyze it, thus smoothing out wrinkles from muscle contraction.
Xeomin® is injected directly into the affected muscles, as are Botox and Dysport. The pain of injection varies, depending on muscle function, extent of injections, and individual personal reaction to the drug. The total dose per muscle is decided by the certified professional, and your condition. Xeomin generally takes 7 days before seeing any improvement, and generally lasts up to 3 months.
Botulinum toxin type A – the active ingredient in XEOMIN® – is used to treat dynamic lines like glabellar frown lines. It acts on nerve endings in muscles to prevent muscle fibers from contracting. By reducing these contractions, XEOMIN® can temporarily reduce the frown lines on your forehead between your eyes.
Manufactured by Merz Pharmaceuticals